$29.63
+0.90 (+3.11%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
-39.7% upside
Low Target
$12.55
Average Target
$17.86
High Target
$20.90
Current Price
$29.63
Current
$29.63
$29.63
Target
$17.86
$17.86
$12.55
$17.86 avg
$20.90
Scenario Analysis
Bear Case
$12.55
-57.6%
Low target
Base Case
$17.86
-39.7%
Avg target
Bull Case
$20.90
+-29.5%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$31.49
-5.9% from high
52-Week Low
$16.00
+85.2% from low
Target vs 52W High
$17.86
-43.3% vs high
Next Earnings Report
Nov 9, 2026
Today
EPS Est: $2.32
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |